Depo-Provera is a Intramuscular Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Pharmacia And Upjohn Company Llc. The primary component is Medroxyprogesterone Acetate.
| Product ID | 0009-7376_057e96a6-abb2-45ba-92bb-eb7dba955361 |
| NDC | 0009-7376 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Depo-Provera |
| Generic Name | Medroxyprogesterone Acetate |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 1992-10-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020246 |
| Labeler Name | Pharmacia and Upjohn Company LLC |
| Substance Name | MEDROXYPROGESTERONE ACETATE |
| Active Ingredient Strength | 150 mg/mL |
| Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1992-10-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020246 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-10-29 |
| Marketing End Date | 2013-09-03 |
| Marketing Category | NDA |
| Application Number | NDA020246 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-10-29 |
| Marketing End Date | 2013-09-03 |
| Marketing Category | NDA |
| Application Number | NDA020246 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-10-29 |
| Marketing End Date | 2013-09-03 |
| Marketing Category | NDA |
| Application Number | NDA020246 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-10-29 |
| Marketing End Date | 2013-09-03 |
| Marketing Category | NDA |
| Application Number | NDA020246 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-10-29 |
| Marketing End Date | 2014-12-31 |
| Marketing Category | NDA |
| Application Number | NDA020246 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-10-29 |
| Marketing Category | NDA |
| Application Number | NDA020246 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-10-29 |
| Marketing End Date | 2013-09-03 |
| Marketing Category | NDA |
| Application Number | NDA020246 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-10-29 |
| Marketing End Date | 2013-09-03 |
| Ingredient | Strength |
|---|---|
| MEDROXYPROGESTERONE ACETATE | 150 mg/mL |
| SPL SET ID: | 199cf13e-0859-4a73-9b45-e700d0cd1049 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0009-0626 | Depo-Provera | medroxyprogesterone acetate |
| 0009-0746 | Depo-Provera | medroxyprogesterone acetate |
| 0009-7376 | Depo-Provera | medroxyprogesterone acetate |
| 50090-0459 | Depo-Provera | Depo-Provera |
| 50090-0665 | Depo-Provera | Depo-Provera |
| 0009-4709 | Depo-SubQ Provera | medroxyprogesterone acetate |
| 0548-5400 | Medroxyprogesterone Acetate | Medroxyprogesterone acetate |
| 0548-5410 | Medroxyprogesterone Acetate | Medroxyprogesterone acetate |
| 0009-0050 | Provera | medroxyprogesterone acetate |
| 0009-0051 | Provera | medroxyprogesterone acetate |
| 0009-0064 | Provera | medroxyprogesterone acetate |
| 0009-0065 | Provera | medroxyprogesterone acetate |
| 0009-0286 | Provera | medroxyprogesterone acetate |
| 0009-0287 | Provera | medroxyprogesterone acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DEPO-PROVERA 76389298 2680672 Live/Registered |
PHARMACIA & UPJOHN COMPANY LLC 2002-03-28 |
![]() DEPO-PROVERA 72107078 0717429 Dead/Cancelled |
Upjohn Company, The 1960-10-24 |